LoginSignup
SOP

Sophia Genetics

Stock
Stock
ISIN: CH1125843347
Ticker: SOPH
CH1125843347
SOPH

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Sophia Genetics is $697.20M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Sophia Genetics's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.151. EPS indicates the company's profitability on a per-share basis.
Currently, 5 analysts cover Sophia Genetics's stock, with a consensus target price of $9.75. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Sophia Genetics reported a revenue of $86.17M.
Sophia Genetics's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$62.14M. EBITDA measures the company's overall financial performance.
Sophia Genetics has a free cash flow of -$45.72M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Sophia Genetics employs approximately 415 people. It operates in the Health Care sector, specifically within the Packaged Software industry.
The free float of Sophia Genetics is 61.34M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$697.20M
EPS (TTM) 
-$1.151
Free Float 
61.34M
Revenue (TTM) 
$86.17M
EBITDA (TTM) 
-$62.14M
Free Cashflow (TTM) 
-$45.72M

Pricing

1D span
$8.031$8.41
52W span
$3.24$8.98

Analyst Ratings

The price target is $9.75 and the stock is covered by 5 analysts.

Buy

5

Hold

0

Sell

0

Information

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Employees
415
Industries
Packaged Software
Sector
Health Care

Identifier

ISIN
CH1125843347
Primary Ticker
SOPH

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin